ALMS (STOCKS)
Alumis Inc. Common Stock
$25.250000
-1.340000 (-5.04%)
Prev close: $26.590000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Martin Babler
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,196.53M
- Employees
- 252
- P/E (TTM)
- -6.90
- P/B (TTM)
- 7.21
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.06 | $-0.93 | -0.1254 | -13.42% |
|
Jun 2025 (Q2)
|
$-1.68 | $-1.41 | -0.2749 | -19.56% |
|
Mar 2025 (Q1)
|
$-1.82 | $-1.52 | -0.3043 | -20.08% |
|
Dec 2024 (Q4)
|
$-0.23 | $-1.42 | +1.1878 | +83.78% |
Financial Statements
| Revenues | $22.12M |
| Nonoperating Income/Loss | $202.27M |
| Operating Expenses | $478.10M |
| Depreciation and Amortization | $3.50M |
| Research and Development | $390.42M |
| Other Operating Expenses | $84.19M |
| Operating Income/Loss | -$455.98M |
| Income/Loss From Continuing Operations After Tax | -$245.15M |
| Income/Loss From Continuing Operations Before Tax | -$245.15M |
| Income Tax Expense/Benefit | -$8.56M |
| Net Income/Loss | -$245.15M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$245.15M |
| Net Income/Loss Available To Common Stockholders, Basic | -$245.15M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.15 |
| Diluted Earnings Per Share | -$2.15 |
| Basic Average Shares | 87,165,583 |
| Diluted Average Shares | 87,165,583 |
| Assets | $488.01M |
| Current Assets | $393.29M |
| Cash | $377.70M |
| Other Current Assets | $15.59M |
| Noncurrent Assets | $94.72M |
| Fixed Assets | $19.06M |
| Other Non-current Assets | $75.67M |
| Liabilities | $103.24M |
| Current Liabilities | $65.42M |
| Accounts Payable | $4.55M |
| Wages | $12.17M |
| Other Current Liabilities | $48.70M |
| Noncurrent Liabilities | $37.83M |
| Equity | $384.77M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $384.77M |
| Liabilities And Equity | $488.01M |
| Net Cash Flow From Operating Activities | -$372.38M |
| Net Cash Flow From Operating Activities, Continuing | -$372.38M |
| Net Cash Flow From Investing Activities | $223.81M |
| Net Cash Flow From Investing Activities, Continuing | $223.81M |
| Net Cash Flow From Financing Activities | $754.00K |
| Net Cash Flow From Financing Activities, Continuing | $754.00K |
| Net Cash Flow | -$147.81M |
| Net Cash Flow, Continuing | -$147.81M |
| Comprehensive Income/Loss | -$245.04M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$245.09M |
| Other Comprehensive Income/Loss | -$110.64M |